Seite wählen

The Working Group on Parenteral Preparations (Arge PareZu) calls on politicians to finally take action to ensure that drug safety and the well-being of patients is not jeopardised in the future. The background of the criticism is the cyto scandal of last year, which is believed to have led to financial damage for the statutory health insurance companies. The PareZu consortium criticises the supra-regional supply structures. The supply close to the place of residence would have to give way more and more in favour of a centralization in the production of cytostatic preparations. However, this has a decisive influence on the shelf life of the drugs. Long transport routes across Germany, mechanical stress caused by transport and temperature fluctuations during transport are important arguments for the legislator to ban supraregional cytoservice supply structures. The advantages of this centralised supply by large cytoservice groups with subsidiaries, such as the avoidance of faulty production or, for example, the elimination of personal responsibility, is of little consequence. The Arge PareZu also believes that parts of the health care system are endangered by speculations of primarily foreign financial investors who have a medium-term profit-making intention with subsequent resale in mind because the investment in medical care centers constructs is intended to control the supply of cytostatic preparations to control market share and maximize profits. According to Arge PareZu, it is not the patient and his or her health that are the focus of financial supporters, but rather the large and fast money generated by speculative objects „Medical Care Centers“. Oncologists would also give up their independence and thus their practices because the financiers are attracting doctors with lucrative employment models. This also influences the prescription behaviour of oncologists, according to the working group, which asks whether this is in the interests of the legislator because structures relevant to care then act in a constructive and not patient-oriented manner.

Source: apotheke adhoc